rss
Ann Rheum Dis 1997;56:690-692 doi:10.1136/ard.56.11.690
  • Concise reports

Treatment of severe and difficult cases of systemic lupus erythematosus with tacrolimus. A report of three cases

  1. M Duddridge,
  2. R J Powell
  1. Clinical Immunology Unit, University Hospital, Queen’s Medical Centre, Nottingham
  1. : Dr M Duddridge, Clinical Immunology Unit, F Floor West Block, University Hospital, Queen’s Medical Centre, Nottingham NG7 2UH.
  • Accepted 2 September 1997

Abstract

OBJECTIVES An analysis of the efficacy of tacrolimus treatment in three patients with difficult and severe systemic lupus erythematosus (SLE) whose active disease had been previously poorly controlled by cyclosporine and cyclophosphamide.

METHODS A review of patient notes.

RESULTS Two patients are well controlled after six and nine months of treatment with tacrolimus 0.06 mg/kg/day and 0.18 mg/kg/day. Previous persistent vasculitis had resolved and other features of active disease were controlled. The third patient’s vasculitis had not improved significantly after two months of treatment and tacrolimus 0.17 mg/kg/day was discontinued because of nephrotoxicity.

CONCLUSION Tacrolimus may be a useful additional immunosuppressive agent in some patients whose SLE is not well controlled by conventional treatments.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF

    Responses

    1. Submit a response
    2. No responses published

    Register for free content

    The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.